| EPE430 | Resilience'¯of an HIV'¯program during'¯COVID-19 facilitates'¯the continuum of care and'¯increases the patient cohort in four provinces in Mozambique | E-poster | Optimizing HIV services (prevention, testing and/or treatment) in the COVID-19 era |
| EPE431 | Telemedicine and E-commerce platforms supporting medical care continuity during the COVID-19 pandemic in Uganda | E-poster | Optimizing HIV services (prevention, testing and/or treatment) in the COVID-19 era |
| EPE432 | Programmatic measures leading to viral load coverage improvement after declining due to the COVID-19 pandemic | E-poster | Optimizing HIV services (prevention, testing and/or treatment) in the COVID-19 era |
| EPE433 | Maintaining ART client retention during the COVID-19 pandemic, St. Carolus Hospital, Jakarta, Indonesia | E-poster | Optimizing HIV services (prevention, testing and/or treatment) in the COVID-19 era |
| EPE434 | Supporting Prevention of Mother-to-Child Transmission of HIV (PMTCT) during the COVID-19 pandemic: lessons from the Kyrgyz Republic | E-poster | Optimizing HIV services (prevention, testing and/or treatment) in the COVID-19 era |
| EPE435 | Use of telehealth in the delivery of HIV services in rural America during COVID-19 Pandemic | E-poster | Optimizing HIV services (prevention, testing and/or treatment) in the COVID-19 era |
| EPE436 | Acceptability of televisits implemented during COVID-19 among adults living with HIV in Chicago | E-poster | Optimizing HIV services (prevention, testing and/or treatment) in the COVID-19 era |
| EPE437 | Reducing interruption in treatment during COVID-19 emergency in Guatemala using differentiated service delivery models | E-poster | Optimizing HIV services (prevention, testing and/or treatment) in the COVID-19 era |
| EPE438 | Using the mobile clinic strategy to provide HIV prevention, testing and treatment services in the community during the COVID-19 lock down in Uganda | E-poster | Optimizing HIV services (prevention, testing and/or treatment) in the COVID-19 era |
| EPE439 | Impact of COVID-19 on HIV research: challenges and opportunities in a clinical trial setting | E-poster | Optimizing HIV services (prevention, testing and/or treatment) in the COVID-19 era |